Nanjing Leads Biolabs Co., Ltd.

HK$36.56As of Sun 8 Nov 2026, 12:00 UTC
HKEX:9887Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (51.55%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (31.92%)
Mkt cap HK$7.134B
ROIC (16.34%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$44
19.30%
(81.64%)
Hold 9|9|7|4|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.38
0.42
0.43
0.46
15.41%
16.72%
19.56%
24.19%
Revenue¥M
471.0
497.4
497.4
484.4
4.31%
9.35%
7.86%
6.80%
Peers (US$910.0M)
Cap (US$)
PE
925.5M
28.74x
886.8M
—
Capital
TTM
5Y
10Y
Leveragex
2.303
(0.136)
(0.112)
EBIT/Intx
2.107
0.770
0.784
Own earn%
118.14
(70.04)
(45.24)
Sh yield%
41.70
10.64
12.33
Owners
Insiders/Inst%
5.54
48.98
Short interest%
5.41
SBC / revenue%
5.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
14–20
$1 testx
—
Incr. ROIC%
3